Neutrophil‐to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio in retinal vein occlusion

REFERENCES

• Klein R, Klein BE, Moss SE et al. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 2000; 98: 133–141.
   PubMedGoogle Scholar
• Rogers S, Mcintosh RL, Cheung N et al. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology 2010; 117: 313–9.e1.
   PubMed Web of Science ®Google Scholar
• Rehak M, Wiedemann P. Retinal vein thrombosis: pathogenesis and management. J Thromb Haemost 2010; 8: 1886–1894.
   PubMed Web of Science ®Google Scholar
• Kesler A, Shalev V, Rogowski O et al. Comparative analysis of homocysteine concentrations in patients with retinal vein occlusion versus thrombotic and atherosclerotic disorders. Blood Coagul Fibrinolysis 2008; 19: 259–262.
   Web of Science ®Google Scholar
• Zahorec R. Ratio of neutrophil to lymphocyte counts–rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lekárske Listy 2001; 102: 5–14.
   PubMedGoogle Scholar
• Sönmez O, Ertas G, Bacaksiz A et al. Relation of neutrophil ‐to‐ lymphocyte ratio with the presence and complexity of coronary artery disease: an observational study. Anadulu Kardiyol Derg 2013; 13: 662–667.
   PubMed Web of Science ®Google Scholar
• Walsh SR, Cook EJ, Goulder F et al. Neutrophil‐lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005; 91: 181–184.
   PubMed Web of Science ®Google Scholar
• Sarraf KM, Belcher E, Raevsky E et al. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non–small cell lung cancer. J Thorac Cardiovasc Surg 2009; 137: 425–428.
   PubMed Web of Science ®Google Scholar
• Krenn‐pilko S, Langsenlehner U, Thurner E‐M et al. The elevated preoperative platelet‐to‐lymphocyte ratio predicts poor prognosis in breast cancer patients. Br J Cancer 2014; 110: 2524–2530.
   PubMed Web of Science ®Google Scholar
• Kuyumcu ME, Yesil Y, Oztürk ZA et al. The evaluation of neutrophil‐lymphocyte ratio in Alzheimer's disease. Dement Geriatr Cogn Disord 2012; 34: 69–74.
   PubMed Web of Science ®Google Scholar
• Walsh PN, Goldberg RE, Tax RL et al. Platelet coagulant activities and retinal vein thrombosis. Thromb Haemost 1977; 38: 399–406.
   Web of Science ®Google Scholar
• Şahin A, Şahin M, Yüksel H et al. The mean platelet volume in patients with retinal vein occlusion. J Ophthalmol 2013; 2013: 236371.
   Web of Science ®Google Scholar
• Asher V, Lee J, Innamaa A et al. Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer. Clin Transl Oncol 2011; 13: 499–503.
   PubMed Web of Science ®Google Scholar
• Yang W, Liu Y. Platelet‐lymphocyte ratio is a predictor of venous thromboembolism in cancer patients. Thromb Res 2015; 136: 212–215.
   Web of Science ®Google Scholar
• Yuksel M, Yildiz A, Toprak N. Platelet‐to‐lymphocyte ratio and no‐reflow phenomenon in patients undergoing primary percutaneous coronary intervention. Am J Cardiol 2015; 115: 280–281.
   Web of Science ®Google Scholar
• Azab B, Shah N, Akerman M et al. Value of platelet/lymphocyte ratio as a predictor of all‐cause mortality after non‐ST‐elevation myocardial infarction. J Thromb Thrombolysis 2012; 34: 326–334.
   PubMed Web of Science ®Google Scholar
• Rath EZ, Frank RN, Shin DH et al. Risk factors for retinal vein occlusions. Ophthalmology 1992; 99: 509–514.
   PubMed Web of Science ®Google Scholar
• Wagner DD, Burger PC. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 2003; 23: 2131–2137.
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138–150.
   PubMed Web of Science ®Google Scholar
• Uthamalingam S, Patvardhan EA, Subramanian S et al. Utility of the neutrophil to lymphocyte ratio in predicting long‐term outcomes in acute decompensated heart failure. Am J Cardiol 2011; 107: 433–438.
   PubMed Web of Science ®Google Scholar
• Duffy BK, Gurm HS, Rajagopal V et al. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long‐term mortality after percutaneous coronary intervention. Am J Cardiol 2006; 97: 993–996.
   PubMed Web of Science ®Google Scholar
• Onsrud M, Thorsby E. Influence of in vivo hydrocortisone on some human blood lymphocyte subpopulations. I. Effect on natural killer cell activity. Scand J Immunol 1981; 13: 573–579.
   Web of Science ®Google Scholar
• Bian C, Wu Y, Shi Y et al. Predictive value of the relative lymphocyte count in coronary heart disease. Heart Vessels 2010; 25: 469–473.
   PubMed Web of Science ®Google Scholar
• Ommen SR, Hodge DO, Rodeheffer RJ et al. Predictive power of the relative lymphocyte concentration in patients with advanced heart failure. Circulation 1998; 97: 19–22.
   PubMed Web of Science ®Google Scholar
• Kalay N, Dogdu O, Koc F et al. Hematologic parameters and angiographic progression of coronary atherosclerosis. Angiology 2012; 63: 213–217.
   PubMed Web of Science ®Google Scholar
• Gibson PH, Cuthbertson BH, Croal BL et al. Usefulness of neutrophil/lymphocyte ratio as predictor of new‐onset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 2010; 105: 186–191.
   PubMed Web of Science ®Google Scholar
• Dursun A, Ozturk S, Yucel H et al. Association of neutrophil/lymphocyte ratio and retinal vein occlusion. Eur J Ophthalmol 2015; 25: 343346.
   Web of Science ®Google Scholar
• Elbey B, Yazgan ÜC, Yıldırım A et al. Mean platelet volume and neutrophil to lymphocyte ratio in patients with vernal keratoconjunctivitis. J Clin Exp Invest 2015; 6: 40–43.
   Google Scholar
• Karaca EE, Özmen MC, Ekici F et al. Neutrophil‐to‐lymphocyte ratio may predict progression in patients with keratoconus. Cornea 2014; 33: 1168–1173.
   PubMed Web of Science ®Google Scholar
• Ilhan N, Daglioglu MC, Ilhan O et al. The significance of the neutrophil/lymphocyte ratio as a simple indicator of inflammation in age‐related macular degeneration. Ocul Immunol Inflamm 2016; 24: 362–363.
   PubMed Web of Science ®Google Scholar
• Tsujikawa A, Ogura Y, Hiroshiba N et al. In vivo evaluation of leukocyte dynamics in retinal ischemia reperfusion injury. Invest Ophthalmol Vis Sci 1998; 39: 793–800.
   PubMed Web of Science ®Google Scholar
• van der Poll T, Büller HR, ten Cate H et al. Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 1990; 322: 1622–1627.
   PubMed Web of Science ®Google Scholar
• Boushey CJ, Beresford SA, Omenn GS et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049–1057.
   PubMed Web of Science ®Google Scholar
• Nguyen NX, Küchle M. Aqueous flare and cells in eyes with retinal vein occlusion–correlation with retinal fluorescein angiographic findings. Br J Ophthalmol 1993; 77: 280–283.
   PubMed Web of Science ®Google Scholar
• Miyake K, Miyake T, Kayazawa F. Blood‐aqueous barrier in eyes with retinal vein occlusion. Ophthalmology 1992; 99: 906–910.
   PubMed Web of Science ®Google Scholar
• Green WR, Chan CC, Hutchins GM et al. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Retina 2005; 25: 27–55.
   PubMed Web of Science ®Google Scholar
• Prisco D, Marcucci R. Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach. Pathophysiol Haemost Thromb 2002; 32: 308–311.
   PubMed Web of Science ®Google Scholar
• Kurtul A, Yarlioglues M, Murat SN et al. Usefulness of the platelet‐to‐lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST‐segment elevation myocardial infarction. Am J Cardiol 2014; 114: 342–347.
   PubMed Web of Science ®Google Scholar
• Balta S, Demırkol S, Kucuk U. The platelet lymphocyte ratio may be useful inflammatory indicator in clinical practice. Hemodial Int 2013; 17: 668–669.
   PubMed Web of Science ®Google Scholar
• Tsiara S, Elisaf M, Jagroop IA et al. Platelets as predictors of vascular risk: is there a practical index of platelet activity? Clin Appl Thromb Hemost 2003; 9: 177–190.
   PubMed Web of Science ®Google Scholar
• Henn V, Slupsky JR, Gräfe M et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391: 591–594.
   PubMed Web of Science ®Google Scholar
• Leoncini G, Bruzzese D, Signorello MG et al. Platelet activation by collagen is increased in retinal vein occlusion. Thromb Haemost 2007; 97: 218–227.
   Web of Science ®Google Scholar
• Oylumlu M, Yıldız A, Oylumlu M et al. Platelet‐to‐lymphocyte ratio is a predictor of in‐hospital mortality patients with acute coronary syndrome. Anatol J Cardiol 2015; 15: 277–283.
   Web of Science ®Google Scholar
• Unal I. Defining an optimal cut‐point value in ROC analysis: an alternative approach. Comput Math Methods Med 2017; 2017: 3762651.
   PubMed Web of Science ®Google Scholar
• Angkananard T, Anothaisintawee T, Ingsathit A et al. Mediation effect of neutrophil lymphocyte ratio on cardiometabolic risk factors and cardiovascular events. Sci Rep 2019; 9: 2618.
   PubMed Web of Science ®Google Scholar
• Atak B, Aktas G, Duman TT et al. Diabetes control could through platelet‐to‐lymphocyte ratio in hemograms. Rev Assoc Med Bras (1992) 2019; 65: 38–42.
   PubMed Web of Science ®Google Scholar